Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients

By Escalante Carmen  

Supportive Care in Cancer, Vol. 12, Iss. 9, 2004-09 ,pp. : 657-662

Springer Publishing Company

Access to resources Recommend Favorite

An Approach to the Design and Implementation of Clinical Trials of Empirical Antibiotic Therapy in Febrile and Neutropenic Cancer Patients

By Viscoli C.   Bruzzi P.   Glauser M.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2013-2022

Elsevier

Access to resources Recommend Favorite

Retrospective Review of Gynecologic Oncology Patients with Therapy-Induced Neutropenic Fever

By McMeekin D.S.   Gazzaniga C.   Berman M.   DiSaia P.   Manetta A.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 247-253

Academic Press

Access to resources Recommend Favorite

Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients: A systematic review of the literature with meta-analysis

By Berghmans T.   Paesmans M.   Lafitte J.   Mascaux C.   Meert A.   Jacquy C.   Burniat A.   Steels E.   Vallot F.   Sculier J.  

Supportive Care in Cancer, Vol. 10, Iss. 3, 2002-04 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children

By Le Guyader N.  

Supportive Care in Cancer, Vol. 12, Iss. 10, 2004-10 ,pp. : 720-724

Springer Publishing Company

Access to resources Recommend Favorite